Share ownership Betta Pharmaceuticals Co., Ltd.

300558

CNE100002DD9

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 2026-01-23			5-day change	1st Jan Change
49.16 ^CNY	+3.10%		-1.25%	+5.29%

01-08	Hangzhou Zhixing Pharmaceutical Co., Ltd. ( announced that it has received funding from Betta Pharmaceuticals Co., Ltd.	CI
12-07	Betta Pharmaceuticals's Four Drugs Placed on China's Insurance Drug List	MT

Share class: Betta Pharmaceuticals Co., Ltd.

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	418,485,885	215,566,338 ( 51.51 %)	0	51.51 %

Major shareholders: Betta Pharmaceuticals Co., Ltd.

Name	Equities	%	Valuation
Ningbo Kaiming Investment Management LP 19.35 %	80,064,000	19.35 %	535 M ¥
Xue Chao Wang 13.13 %	54,324,000	13.13 %	363 M ¥
Hangzhou Terui Venture Management Partnership LP 6.961 %	28,797,061	6.961 %	192 M ¥
Aegon-Industrial Fund Management Co., Ltd. 2.714 %	11,228,661	2.714 %	75 M ¥
Lie Ming Ding 2.399 %	9,924,563	2.399 %	66 M ¥
Yin Xin Wang 1.198 %	4,954,477	1.198 %	33 M ¥
Zhong Ou Asset Management Co., Ltd 1.118 %	4,624,648	1.118 %	31 M ¥
Zhu Shen 1.111 %	4,596,000	1.111 %	31 M ¥
New China Asset Management Co., Ltd. 1.108 %	4,582,100	1.108 %	31 M ¥
China Southern Asset Management Co., Ltd. 1.086 %	4,492,922	1.086 %	30 M ¥
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Other	26.32%
Individuals	17.84%
Institutional	14.16%
Unknown	41.68%

Based on 1000 largest holdings

Geographical origin of shareholders

China	40.47%
Individuals	17.84%

Based on 1000 largest holdings

Betta Pharmaceuticals Co Ltd is a company mainly engaged in research, development, production and sales of innovative drugs for the treatment of malignant tumors. The Company's primary product is its self-developed icotinib hydrochloride (Conmana), a small molecule targeted anticancer drug used for the treatment of lung cancer. The Company is also engaged in promotional services, real estate leasing and other businesses.

Employees

1,961

Sector

Pharmaceuticals

Calendar

04-22 - Q4 2025 Earnings Release

More about the company